Valeant names new chief executive

April 25, 2016

Embattled Canadian pharmaceutical company Valeant named as its new chief executive and chairman on Monday Joseph Papa, who has left his post leading Perrigo, a maker of over-the-counter medical products.

Papa, 60, will succeed outgoing Valeant CEO Michael Pearson as the company faces criticism over its accounting and drug-pricing policies.

Last month, Valeant Pharmaceuticals International announced Pearson would step down once a successor was identified.

"The Board has conducted a thorough search process and believes that Joe is the ideal leader for Valeant at this time," said Valeant chairman Robert Ingram in a statement.

Ingram praised Papa's , deep experience in the global pharma business and said he was known for "fostering an ethical culture."

Perrigo announced separately that it had promoted president John Hendrickson to chief executive in light of Papa's departure.

Shares of Perrigo slumped 11.2 percent to $107.81 in opening trade, while Valeant rose 2.3 percent to $36.86.

Explore further: Valeant CEO takes medical leave

Related Stories

Valeant CEO takes medical leave

December 28, 2015
Valeant Pharmaceuticals CEO J. Michael Pearson is taking a medical leave of absence after he was hospitalized with pneumonia last week.

Valeant under US federal investigation over drug pricing

October 15, 2015
Canadian pharmaceutical group Valeant says it has received subpoenas from US federal prosecutors seeking information about the pricing and distribution of its drugs, along with how it makes them more affordable for patients.

Valeant mulls sale of business tied to drug price hikes

October 19, 2015
Controversial pharma company Valeant signaled Monday it expects to dispose of a business associated with large drug price increases and foresees much more modest price hikes in the future.

Mylan takes takeover bid to Perrigo shareholders

September 8, 2015
Pharmaceutical company Mylan said Tuesday that it would take its offer to buy Perrigo directly to Perrigo shareholders following refusals by the company's management to engage in merger talks.

Valeant shares plunge 49% on default warning, outlook

March 15, 2016
Canadian drugmaker Valeant's share price plunged nearly 50 percent Tuesday after it warned it was at risk of a debt default and slashed its earnings forecast.

Allergan tells shareholders to reject Valeant deal

June 23, 2014
Allergan, the maker of Botox, said Monday that Valeant Pharmaceuticals' hostile takeover bid for the company is "grossly inadequate" and that shareholders should reject it.

Recommended for you

Tongue-in-cheek Nobels honor nutritional analysis of cannibalism, roller-coaster kidney stones treatment

September 14, 2018
A nutritional analysis of cannibalism and treating kidney stones on roller-coasters were research projects honored by tongue-in-cheek awards at Harvard University Thursday, designed to make you laugh first, and think later.

Pediatric robot patient offers new level of realism for doctors in training

September 10, 2018
A team of researchers and engineers at Gaumard Scientific has unveiled a new robot that raises the bar on medical training devices. The robot, called HAL, has been made to look like a five-year-old male patient and offers ...

Why men say they've had more lifetime sexual partners than women

July 25, 2018
The disparity between the number of sexual partners reported by men and women can largely be explained by a tendency among men to report extreme numbers of partners, and to estimate rather than count their lifetime total, ...

Censors jump into action as China's latest vaccine scandal ignites

July 22, 2018
Chinese censors on Sunday deleted articles and postings about the vaccine industry as an online outcry over the country's latest vaccine scandal intensified.

Revenge of a forgotten medical 'genius'

June 30, 2018
It's not an uncommon fate for a pioneering scientist: languishing unrecognised in his time before dying in obscurity. But as his 200th birthday approaches, the life-saving work of a Hungarian obstetrician is finally getting ...

Yes, you can put too much chlorine in a pool

June 2, 2018
(HealthDay)—Before you take a dip in the pool this summer, be sure there's not too much chlorine in the water.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.